CareDx (CDNA)

• Market cap: $820M
• 1 day: 0.44%
• 5 days: -0.38%
• 1 month: 11.08%
• 3 months: 34.86%
• 6 months: -0.5%
• Year to date: -25.93%
• 1 year: -26.03%
• 5 years: -71.04%
• 10 years: 222.02%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Employees: 650